Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease

Treatment with dopaminergic agents result excessive daytime sleepiness (EDS) and some studies have shown the benefit of using modafinil for treating excessive daytime sleepiness of Parkinson's disease (PD) patient. We investigated whether modafinil have ameliorative properties against levodopa...

Full description

Bibliographic Details
Main Authors: Rina Ando, Mohammed Emamussalehin Choudhury, Yuki Yamanishi, Win Thiri Kyaw, Madoka Kubo, Mariko Kannou, Noriko Nishikawa, Junya Tanaka, Masahiro Nomoto, Masahiro Nagai
Format: Article
Language:English
Published: Elsevier 2018-04-01
Series:Journal of Pharmacological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861318300586
_version_ 1811199457330462720
author Rina Ando
Mohammed Emamussalehin Choudhury
Yuki Yamanishi
Win Thiri Kyaw
Madoka Kubo
Mariko Kannou
Noriko Nishikawa
Junya Tanaka
Masahiro Nomoto
Masahiro Nagai
author_facet Rina Ando
Mohammed Emamussalehin Choudhury
Yuki Yamanishi
Win Thiri Kyaw
Madoka Kubo
Mariko Kannou
Noriko Nishikawa
Junya Tanaka
Masahiro Nomoto
Masahiro Nagai
author_sort Rina Ando
collection DOAJ
description Treatment with dopaminergic agents result excessive daytime sleepiness (EDS) and some studies have shown the benefit of using modafinil for treating excessive daytime sleepiness of Parkinson's disease (PD) patient. We investigated whether modafinil have ameliorative properties against levodopa induced excessive nighttime sleepiness (ENS) in MPTP-treated murine nocturnal PD model. Our EEG analyses of whole day recordings revealed that modafinil reduce ENS of this nocturnal PD models with levodopa medications. Therefore, we investigated whether, modafinil post-treatment followed by MPTP shows any effect on monoamine contents of brain and found to robustly increased noradrenaline (NA) concentration of MPTP treated mice. Modafinil post-treatment, in neurorestorative context (5 days post-lesion) led to increased striatal dopamine (DA) concentrations of MPTP-treated mice. Here, we first confirmed that modafinil ameliorates levodopa induced excessive sleepiness and restores monoaminergic systems. The arousal and anti-parkinsonian effects displayed by modafinil indicate that in combination with dopaminergic agents, modafinil co-administration may be worthwhile in trying to suppress the excessive daytime sleepiness and progressive dopaminergic neuron loss in PD. Keywords: Parkinson's disease, Excessive day time sleepiness, Monoamines, MPTP, Modafinil, Neurorestoration, Nocturnal
first_indexed 2024-04-12T01:49:32Z
format Article
id doaj.art-905c855158434995a0937f980edf8a77
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-04-12T01:49:32Z
publishDate 2018-04-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-905c855158434995a0937f980edf8a772022-12-22T03:52:59ZengElsevierJournal of Pharmacological Sciences1347-86132018-04-011364266271Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's diseaseRina Ando0Mohammed Emamussalehin Choudhury1Yuki Yamanishi2Win Thiri Kyaw3Madoka Kubo4Mariko Kannou5Noriko Nishikawa6Junya Tanaka7Masahiro Nomoto8Masahiro Nagai9Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, JapanDepartment of Molecular and Cellular Physiology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan; Corresponding author. Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Toon, Ehime, 791-0295, Japan.Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, JapanDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, JapanDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, JapanDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, JapanDepartment of Neurology, National Center Hospital of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8551, JapanDepartment of Molecular and Cellular Physiology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, JapanDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, JapanDepartment of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, JapanTreatment with dopaminergic agents result excessive daytime sleepiness (EDS) and some studies have shown the benefit of using modafinil for treating excessive daytime sleepiness of Parkinson's disease (PD) patient. We investigated whether modafinil have ameliorative properties against levodopa induced excessive nighttime sleepiness (ENS) in MPTP-treated murine nocturnal PD model. Our EEG analyses of whole day recordings revealed that modafinil reduce ENS of this nocturnal PD models with levodopa medications. Therefore, we investigated whether, modafinil post-treatment followed by MPTP shows any effect on monoamine contents of brain and found to robustly increased noradrenaline (NA) concentration of MPTP treated mice. Modafinil post-treatment, in neurorestorative context (5 days post-lesion) led to increased striatal dopamine (DA) concentrations of MPTP-treated mice. Here, we first confirmed that modafinil ameliorates levodopa induced excessive sleepiness and restores monoaminergic systems. The arousal and anti-parkinsonian effects displayed by modafinil indicate that in combination with dopaminergic agents, modafinil co-administration may be worthwhile in trying to suppress the excessive daytime sleepiness and progressive dopaminergic neuron loss in PD. Keywords: Parkinson's disease, Excessive day time sleepiness, Monoamines, MPTP, Modafinil, Neurorestoration, Nocturnalhttp://www.sciencedirect.com/science/article/pii/S1347861318300586
spellingShingle Rina Ando
Mohammed Emamussalehin Choudhury
Yuki Yamanishi
Win Thiri Kyaw
Madoka Kubo
Mariko Kannou
Noriko Nishikawa
Junya Tanaka
Masahiro Nomoto
Masahiro Nagai
Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease
Journal of Pharmacological Sciences
title Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease
title_full Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease
title_fullStr Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease
title_full_unstemmed Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease
title_short Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease
title_sort modafinil alleviates levodopa induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of parkinson s disease
url http://www.sciencedirect.com/science/article/pii/S1347861318300586
work_keys_str_mv AT rinaando modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT mohammedemamussalehinchoudhury modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT yukiyamanishi modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT winthirikyaw modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT madokakubo modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT marikokannou modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT norikonishikawa modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT junyatanaka modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT masahironomoto modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease
AT masahironagai modafinilalleviateslevodopainducedexcessivenighttimesleepinessandrestoresmonoaminergicsystemsinanocturnalanimalmodelofparkinsonsdisease